38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Tokyo Guidelines 2018: surgical management of acute cholecystitis: safe steps in laparoscopic cholecystectomy for acute cholecystitis (with videos)

      1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 14 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 15 , 27 , 28 , 11 , 29 , 30 , 28 , 31 , 32 , 33 , 34 , 33 , 35 , 36 , 37 , 38 , 39 , 40 , 10 , 41 , 42 , 43 , 44 , 2 , 45 , 46 , 47 , 32
      Journal of Hepato-Biliary-Pancreatic Sciences
      Wiley

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In some cases, laparoscopic cholecystectomy (LC) may be difficult to perform in patients with acute cholecystitis (AC) with severe inflammation and fibrosis. The Tokyo Guidelines 2018 (TG18) expand the indications for LC under difficult conditions for each level of severity of AC. As a result of expanding the indications for LC to treat AC, it is absolutely necessary to avoid any increase in bile duct injury (BDI), particularly vasculo-biliary injury (VBI), which is known to occur at a certain rate in LC. Since the Tokyo Guidelines 2013 (TG13), an attempt has been made to assess intraoperative findings as objective indicators of surgical difficulty; based on expert consensus on these difficulty indicators, bail-out procedures (including conversion to open cholecystectomy) have been indicated for cases in which LC for AC is difficult to perform. A bail-out procedure should be chosen if, when the Calot's triangle is appropriately retracted and used as a landmark, a critical view of safety (CVS) cannot be achieved because of the presence of nondissectable scarring or severe fibrosis. We propose standardized safe steps for LC to treat AC. To achieve a CVS, it is vital to dissect at a location above (on the ventral side of) the imaginary line connecting the base of the left medial section (Segment 4) and the roof of Rouvière's sulcus and to fulfill the three criteria of CVS before dividing any structures. Achieving a CVS prevents the misidentification of the cystic duct and the common bile duct, which are most commonly confused. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47. Related clinical questions and references are also included.

          Related collections

          Most cited references93

          • Record: found
          • Abstract: found
          • Article: not found

          Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis.

          We propose a new flowchart for the treatment of acute cholecystitis (AC) in the Tokyo Guidelines 2018 (TG18). Grade III AC was not indicated for straightforward laparoscopic cholecystectomy (Lap-C). Following analysis of subsequent clinical investigations and drawing on Big Data in particular, TG18 proposes that some Grade III AC can be treated by Lap-C when performed at advanced centers with specialized surgeons experienced in this procedure and for patients that satisfy certain strict criteria. For Grade I, TG18 recommends early Lap-C if the patients meet the criteria of Charlson comorbidity index (CCI) ≤5 and American Society of Anesthesiologists physical status classification (ASA-PS) ≤2. For Grade II AC, if patients meet the criteria of CCI ≤5 and ASA-PS ≤2, TG18 recommends early Lap-C performed by experienced surgeons; and if not, after medical treatment and/or gallbladder drainage, Lap-C would be indicated. TG18 proposes that Lap-C is indicated in Grade III patients with strict criteria. These are that the patients have favorable organ system failure, and negative predictive factors, who meet the criteria of CCI ≤3 and ASA-PS ≤2 and who are being treated at an advanced center (where experienced surgeons practice). If the patient is not considered suitable for early surgery, TG18 recommends early/urgent biliary drainage followed by delayed Lap-C once the patient's overall condition has improved. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47. Related clinical questions and references are also included.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            One-wound laparoscopic cholecystectomy.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Intraoperative cholangiography and risk of common bile duct injury during cholecystectomy.

              Intraoperative cholangiography (IOC) may decrease the risk of common bile duct (CBD) injury during cholecystectomy by helping to avoid misidentification of the CBD. To characterize the relationship of IOC use and CBD injury while controlling for patient and surgeon characteristics. Retrospective nationwide cohort analysis of Medicare patients undergoing cholecystectomy from January 1, 1992, to December 31, 1999. Patients were identified using Current Procedural Terminology codes from the Medicare Part B depository. Common bile duct injury was defined by a second surgical procedure to repair the CBD injury within 1 year of cholecystectomy. Surgeon demographic features were obtained from matching the Medicare Part B data to the American Medical Association Physician Masterfile database. Frequency of CBD injury in patients who did and did not have IOC performed during cholecystectomy, controlling for patient-level (age, sex, race, and case complexity) and surgeon-level (surgeon's age, sex, race, year of surgical procedure, case order, percentage of IOC use in prior surgical procedures, years in medical practice, board certification, and specialization) factors. The database search identified 1 570 361 cholecystectomies and 7911 CBD injuries (0.5%). Common bile duct injury was found in 2380 (0.39%) of 613 706 patients undergoing cholecystectomy with IOC and in 5531 (0.58%) of 956 655 patients undergoing cholecystectomy without IOC (unadjusted relative risk, 1.49; 95% confidence interval, 1.42-1.57). After controlling for patient-level factors and surgeon-level factors, the risk of injury was increased when IOC was not used (adjusted relative risk, 1.71; 95% confidence interval, 1.38-2.28). While surgeons performing IOCs routinely had a lower rate of CBD injuries than those who did not, this difference disappeared when IOC was not used. In this study of Medicare patients undergoing cholecystectomy in the 1990s, the risk of CBD injury was significantly higher when IOC was not used. Although IOCs may not prevent all CBD injuries, this study suggests that the routine use of IOC may decrease the rate of CBD injury.
                Bookmark

                Author and article information

                Journal
                Journal of Hepato-Biliary-Pancreatic Sciences
                J Hepatobiliary Pancreat Sci
                Wiley
                18686974
                January 2018
                January 2018
                January 10 2018
                : 25
                : 1
                : 73-86
                Affiliations
                [1 ]Department of Surgery; Ageo Central General Hospital; Saitama Japan
                [2 ]Department of Gastroenterological and Pediatric Surgery; Oita University Faculty of Medicine; Oita Japan
                [3 ]Department of Surgery; Keio University School of Medicine; Tokyo Japan
                [4 ]Department of Surgery; Teikyo University School of Medicine; Tokyo Japan
                [5 ]Section of Hepato-Pancreato-Biliary Surgery; Washington University School of Medicine in St. Louis; St. Louis MO USA
                [6 ]Department of Surgery; Mayo Clinic College of Medicine; Jacksonville FL USA
                [7 ]Department of Gastroenterological Surgery; Yokohama City University Graduate School of Medicine; Kanagawa Japan
                [8 ]Minimally Invasive Surgery Center; Yotsuya Medical Cube; Tokyo Japan
                [9 ]Department of Surgery; Toho University Ohashi Medical Center; Tokyo Japan
                [10 ]Department of Surgery; Fujinomiya City General Hospital; Shizuoka Japan
                [11 ]Department of Surgery and Oncology; Graduate School of Medical Sciences; Kyushu University; Fukuoka Japan
                [12 ]Department of Surgery; Center for Gastroenterology and Liver Disease; Kitakyushu City Yahata Hospital; Fukuoka Japan
                [13 ]Lewis Katz School of Medicine at Temple University; Philadelphia PA USA
                [14 ]Department of Surgery; Seoul National University Bundang Hospital; Seoul National University College of Medicine; Seoul Korea
                [15 ]Division of General Surgery; Linkou Chang Gung Memorial Hospital; Taoyuan Taiwan
                [16 ]Department of Surgery; Yonsei University Gangnam Severance Hospital; Seoul Korea
                [17 ]Department of Surgery; Konyang University Hospital; Daejeon Korea
                [18 ]Department of Surgery; Show Chwan Memorial Hospital; Changhua Taiwan
                [19 ]Chair of General Surgery and Minimal Invasive Surgery “Taquini” University of Buenos Aires; DAICIM Foundation; Buenos Aires Argentina
                [20 ]Clinical Surgery; University of Edinburgh; Edinburgh UK
                [21 ]Department of Surgery; Academic Medical Center; Amsterdam The Netherlands
                [22 ]Department of General and HPB Surgery; Loreto Nuovo Hospital; Naples Italy
                [23 ]First Department of Surgery; Agia Olga Hospital; Athens Greece
                [24 ]Department of Surgical Oncology; Lilavati Hospital and Research Centre; Mumbai India
                [25 ]Department of Surgery; Surgery Centre; Hong Kong Sanatorium and Hospital; Hong Kong
                [26 ]Faculty of Medicine; The Chinese University of Hong Kong; Shatin Hong Kong
                [27 ]Department of Surgery; Cheng Hsin General Hospital; Taipei Taiwan
                [28 ]Department of Surgery; The Jikei University Kashiwa Hospital; Chiba Japan
                [29 ]Department of Gastroenterological Surgery; Fujita Health University School of Medicine; Aichi Japan
                [30 ]Department of Surgery; Dokkyo Medical University Koshigaya Hospital; Saitma Japan
                [31 ]Department of Surgery; Institute of Gastroenterology; Tokyo Women's Medical University; Tokyo Japan
                [32 ]Director; Mie Prefectural Ichishi Hospital; Mie Japan
                [33 ]Department of General Internal Medicine; Japanese Red Cross Nagoya Daini Hospital; Aichi Japan
                [34 ]Department of Family Medicine; Mie Prefectural Ichishi Hospital; Mie Japan
                [35 ]Hepatobiliary Center; Paul Brousse Hospital; Villejuif France
                [36 ]Department of Surgery; Tokyo Metropolitan Komagome Hospital; Tokyo Japan
                [37 ]Department of Surgery; Fujita Health University School of Medicine; Aichi Japan
                [38 ]Department of Surgery, Hospital Italiano; University of Buenos Aires; Buenos Aires Argentina
                [39 ]Department of Surgical Gastroenterology; Seth G S Medical College and K E M Hospital; Mumbai India
                [40 ]Department of Surgery; Tohoku Rosai Hospital; Miyagi Japan
                [41 ]Department of Hemodialysis and Surgery; Ichikawa Hospital; International University of Health and Welfare; Chiba Japan
                [42 ]Department of EBM and Guidelines; Japan Council for Quality Health Care; Tokyo Japan
                [43 ]Department of Emergency Medicine; School of Medicine University of Occupational and Environmental Health; Fukuoka Japan
                [44 ]President; Oita University; Oita Japan
                [45 ]Department of Surgery; JR Sapporo Hospital; Hokkaido Japan
                [46 ]Director; Toho University; Tokyo Japan
                [47 ]Department of Gastroenterology; Second Teaching Hospital; Fujita Health University; Aichi Japan
                Article
                10.1002/jhbp.517
                29095575
                ef5a187f-7930-4e91-958f-59f02ef4b3df
                © 2018

                http://doi.wiley.com/10.1002/tdm_license_1.1

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                History

                Comments

                Comment on this article